Cutler Group LP Biocryst Pharmaceuticals Inc Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 07, 2023	SELL	$10.5 - $14.2 $36,750 - $49,700	-3,500 Reduced 59.32%	2,400 $0
Q3 2022 Oct 25, 2022	SELL	$10.79 - $14.81 $29,132 - $39,987	-2,700 Reduced 31.4%	5,900 $1,000
Q2 2022 Aug 04, 2022	SELL	$7.89 - $17.88 $165,690 - $375,480	-21,000 Reduced 70.95%	8,600 $1,000
Q1 2022 Apr 14, 2022	BUY	$11.56 - $19.76 $194,208 - $331,968	16,800 Added 131.25%	29,600 $15,000
Q4 2021 Jan 18, 2022	SELL	$11.18 - $15.46 $6,708 - $9,276	-600 Reduced 4.48%	12,800 $6,000
Q3 2021 Oct 26, 2021	BUY	$14.21 - $17.65 $21,315 - $26,474	1,500 Added 12.61%	13,400 $7,000
Q2 2021 Jul 19, 2021	BUY	$9.5 - $17.24 $113,050 - $205,155	11,900 New	11,900 $5,000
Q3 2020 Oct 27, 2020	SELL	$3.43 - $5.53 $51,793 - $83,503	-15,100 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$1.9 - $5.61 $28,690 - $84,711	15,100 New	15,100 $13,000
Q3 2019 Oct 28, 2019	SELL	$2.5 - $3.73 $4,750 - $7,087	-1,900 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$2.91 - $9.15 $291 - $915	-100 Reduced 5.0%	1,900 $0
Q1 2019 May 10, 2019	SELL	$7.38 - $9.72 $66,420 - $87,480	-9,000 Reduced 81.82%	2,000 $5,000
Q4 2018 Feb 05, 2019	BUY	$6.51 - $9.6 $25,389 - $37,440	3,900 Added 54.93%	11,000 $9,000
Q3 2018 Nov 07, 2018	BUY	$5.52 - $7.99 $35,328 - $51,136	6,400 Added 914.29%	7,100 $6,000
Q2 2018 Aug 10, 2018	SELL	$4.6 - $6.52 $459 - $652	-100 Reduced 12.5%	700 $0
Q1 2018 May 11, 2018	SELL	$4.35 - $5.82 $434 - $582	-100 Reduced 11.11%	800 $0
Q4 2017 Jan 17, 2018	SELL	$4.16 - $5.33 $42,016 - $53,833	-10,100 Reduced 91.82%	900 $0
Q3 2017 Oct 17, 2017	BUY	$4.1 - $5.97 $45,099 - $65,670	11,000	11,000 $4,000

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

Vanguard Group Inc Valley Forge, PA

20.3M
Shares

$158 Million
0.0% of portfolio
Black Rock Inc. New York, NY

20M
Shares

$155 Million
0.0% of portfolio
Avoro Capital Advisors LLC New York, NY

11.9M
Shares

$92.3 Million
1.36% of portfolio
Kynam Capital Management, LP Princeton, NJ

9.09M
Shares

$70.7 Million
5.66% of portfolio
State Street Corp Boston, MA

8.85M
Shares

$68.8 Million
0.0% of portfolio

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.45B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account